$32.89
Amizon Max is an antiviral agent for systemic use. It is indicated for the treatment of influenza and acute respiratory viral infections.
Amizon Max is an antiviral agent for systemic use. It is indicated for the treatment of influenza and acute respiratory viral infections.
Hypersensitivity to drugs containing iodide, molecular iodine or covalently bound iodine, as well as to other components of the drug.
Amizon Max should be taken orally, without chewing, 2 hours before meals.
Adults are prescribed a dose of 500 mg (0.5 g) 3 times or 1000 mg (1 g) 2 times a day.
The maximum single dose is 1000 mg (1 g), daily dose is 2000 mg (2 g).
Duration of treatment is 7 days.
Enisamium iodide intake leads to an increase in plasma iodide levels. The secondary increase in circulating iodide levels triggers a self-regulation mechanism of thyroid function, in which the uptake of inorganic iodide by thyrocytes is inhibited, which helps prevent excessive production of thyroid hormones; at the same time, the level of thyroid-stimulating hormone increases transiently (Wolf-Chaikoff phenomenon). This effect lasts for several days; after discontinuation of treatment, thyroid function returns to normal. In some cases, a transient increase in thyroid-stimulating hormone has been observed for several weeks.
The drug is contraindicated for use during pregnancy, as clinical studies of enisamium iodide have not been conducted in pregnant women.
The drug in this dosage form should not be used in children.
Taking Amizon Max does not affect the ability to drive or operate other mechanisms.
No reports of overdose with Amizon Max were received in clinical trials and during post-marketing use.
Infections and invasions: folliculitis, nasopharyngitis, rhinitis.
Respiratory, thoracic and mediastinal disorders: dyspnea.
Blood and lymphatic system disorders: lymphadenopathy.
Nervous system disorders: headache, dizziness.
Visual disorders: eyelid edema.
Store in a dry place, protected from light, at a temperature not exceeding 25°C. Keep out of the reach of children.
Reviews
There are no reviews yet.